Expression profiling characterization of laminin α-2 positive MDC

Biochemical and Biophysical Research Communications

Volumn 350, Issue 2, 2006, Pages 345-351

  Millino, Caterina ^a   Bellin, Milena ^a   Fanin, Marina ^b   Romualdi, Chiara ^a   Pegoraro, Elena ^b   Angelini, Corrado ^b   Lanfranchi, Gerolamo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

Congenital muscular dystrophies; Expression profiling; Muscle specific microarray; Patient characterization

Indexed keywords

LAMININ ALPHA2; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 3; MYOSIN LIGHT CHAIN 4; PROTEIN DERIVATIVE; TELETHONIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FAST MUSCLE FIBER; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MUSCULAR DYSTROPHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SKELETAL MUSCLE; SLOW MUSCLE FIBER;

CREATINE KINASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LAMININ; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES;

EID: 33749354868     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.063     Document Type: Article

References (27)

1. Dubowitz V., and Fardeau M. Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. Neuromuscul. Disord. 5 (1995) 253-258
2. Voit T. Congenital muscular dystrophies: 1997 update. Brain Dev. 20 (1998) 65-74
3. F. Muntoni, P. Guicheney, in: 85th ENMC International Workshop on Congenital Muscular Dystrophy, 6th International CMD Workshop, 1st Workshop of the Myo-Cluster Project 'GENRE', Neuromuscul. Disord. 12, 2002, pp. 69-78.
4. Muntoni F., and Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul. Disord. 14 (2004) 635-649
5. Helbling-Leclerc A., Zhang X., Topaloglu H., Cruaud C., Tesson F., Weissenbach J., Tome F.M., Schwartz K., Fardeau M., Tryggvason K., and Guicheney P. Mutations in the laminin α 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet. 11 (1995) 216-218
6. Timpl R., Rohde H., Robey P.G., Rennard S.I., Foidart J.M., and Martin G.R. Laminin: a glycoprotein from basement membranes. J. Biol. Chem. 254 (1979) 9933-9937
7. Wewer U.M., and Engvall E. Merosin/laminin-2 and muscular dystrophy. Neuromuscul. Disord. 6 (1996) 409-418
8. Vachon P.H., Xu H., Liu L., Loechel F., Hayashi Y., Arahata K., Reed J.C., Wewer U.M., and Engvall E. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 100 (1997) 1870-1881
9. Pegoraro E., Marks H., Garcias C.A., Crawford T., Connolly A.M., Fanin M., Martinello F., Trevisan C.P., Angelini C., Stella A., Scavina M., Munk R.L., Servidei S., Bönnemann C.C., Bertorini T., Acsadi G., Thompson C.E., Gagnon D., Hoganson G., Carver V., and Hoffman E.P. Laminin α2 muscular dystrophy: genotype/phenotype study in 22 patients. Neurology 51 (1998) 101-110
10. Pegoraro E., Fanin M., Trevisan C., Angelini C., and Hoffman E.P. A novel laminin α2 isoform in severe laminin α2 deficient congenital muscular dystrophy. Neurology 55 (2000) 1128-1134
11. Prandini P., Berardinelli A., Fanin M., Morello F., Zardini E., Pichiecchio A., Uggetti C., Lanzi G., Angelini C., and Pegoraro E. LAMA2 loss-of-function mutation in a girl with a mild congenital muscular dystrophy. Neurology 63 (2004) 1118-1121
12. Campanaro S., Romualdi C., Fanin M., Celegato B., Pacchioni B., Trevisan S., Laveder P., De Pittà C., Pegoraro E., Hayashy Y.K., Valle G., Angelici C., and Lanfranchi G. Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum. Mol. Genet. 11 (2002) 3283-3298
13. Chen Y.W., Zhao P., Borup R., and Hoffman E.P. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151 (2000) 1321-1336
14. Haslett J.N., Sanoudou D., Kho A.T., Bennett R.R., Greenberg S.A., Kohane I.S., Beggs A.H., and Kunkel L.M. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl. Acad. Sci. USA 99 (2002) 15000-15005
15. Noguchi S., Tsukahara T., Fujita M., Kurokawa R., Tachikawa M., Toda T., Tsujimoto A., Arahata K., and Nishino I. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum. Mol. Genet. 12 (2003) 595-600
16. Sung S.S., Brassington A.M., Grannatt K., Rutherford A., Whitby F.G., Krakowiak P.A., Jorde L.B., Carey J.C., and Bamshad M. Mutations in genes encoding fast-twitch contractile proteins cause distal arthrogryposis syndromes. Am. J. Hum. Genet. 72 (2003) 681-690
17. Lin J., Wu H., Tarr P.T., Zhang C.Y., Wu Z., Boss O., Michael L.F., Puigserver P., Isotani E., Olson E.N., Lowell B.B., Bassel-Duby R., and Spiegelman B.M. Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibres. Nature 418 (2002) 797-801
18. 2+ ATPase, are associated with Brody disease. Nat. Genet. 14 (1996) 191-194
19. Kreuder J., Borkhardt A., Repp R., Pekrun A., Gottsche B., Gottschalk U., Reichmann H., Schachenmayr W., Schlegel K., and Lampert F. Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N Engl. J. Med. 334 (1996) 1100-1104
20. Backhus L.E., De Risi J., Brown P.O., and Bisson L.F. Functional genomic analysis of a commercial wine strain of Saccharomyces cerevisiae under differing nitrogen conditions. FEMS Yeast Res. 1 (2001) 111-125
21. Uechi T., Tanaka T., and Kenmochi N. A complete map of the human ribosomal protein genes: assignment of 80 genes to the cytogenetic map and implications for human disorders. Genomics 72 (2001) 223-230
22. Marechal V., Elenbaas B., Piette J., Nicolas J.C., and Levine A.J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14 (1994) 7414-7420
23. Wool I.G. Extraribosomal functions of ribosomal proteins. Trends Biochem. Sci. 21 (1996) 164-165
24. Kim J., Chubatsu L.S., Admon A., Stahl J., Fellous R., and Linn S. Implication of mammalian ribosomal protein S3 in the processing of DNA damage. J. Biol. Chem. 270 (1995) 13620-13629
25. Poetter K., Jiang H., Hassanzadeh S., Master S.R., Chang A., Dalakas M.C., Rayment I., Sellers J.R., Fananapazir L., and Epstein N.D. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. 13 (1996) 63-69
26. Martinsson T., Oldfors A., Darin N., Berg K., Tajsharghi H., Kyllerman M., and Wahlstrom J. Autosomal dominant myopathy: missense mutation (glu706-to-lys) in the myosin heavy chain IIa gene. Proc. Nat. Acad. Sci. 97 (2000) 14614-14619
27. Gerull B., Gramlich M., Atherton J., McNabb M., Trombitas K., Sasse-Klaassen S., Seidman J.G., Seidman C., Granzier H., Labeit S., Frenneaux M., and Thierfelder L. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat. Genet. 30 (2002) 201-204